微创与开腹胰十二指肠切除术治疗良性、癌前病变和恶性疾病。
Minimally invasive versus open pancreatoduodenectomy in benign, premalignant, and malignant disease.
机构信息
Department of Medical Imaging, Radboud University Medical Center Nijmegen, Nijmegen, Netherlands.
Department of Surgery, Radboud University Medical Center, Nijmegen, Netherlands.
出版信息
Cochrane Database Syst Rev. 2024 Jul 26;7(7):CD014017. doi: 10.1002/14651858.CD014017.
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of laparoscopic or robot-assisted pancreatoduodenectomy versus open pancreatoduodenectomy for people with benign, premalignant, and malignant disease.
摘要
这是一份 Cochrane 综述（干预措施）的方案。其目的如下：评估腹腔镜或机器人辅助胰十二指肠切除术与开腹胰十二指肠切除术治疗良性、癌前病变和恶性疾病患者的疗效和安全性。
相似文献
1
Minimally invasive versus open pancreatoduodenectomy in benign, premalignant, and malignant disease.
Cochrane Database Syst Rev. 2024 Jul 26;7(7):CD014017. doi: 10.1002/14651858.CD014017.
2
Minimally invasive versus open pancreatoduodenectomy (LEOPARD-2): study protocol for a randomized controlled trial.
Trials. 2018 Jan 3;19(1):1. doi: 10.1186/s13063-017-2423-4.
3
Development of Minimally Invasive Pancreatic Surgery: an Evidence-Based Systematic Review of Laparoscopic Versus Robotic Approaches.
J Gastrointest Surg. 2016 Sep;20(9):1658-65. doi: 10.1007/s11605-016-3204-1. Epub 2016 Jul 13.
4
Robot-assisted versus laparoscopic pancreatoduodenectomy: a pan-European multicenter propensity-matched study.
Surgery. 2024 Jun;175(6):1587-1594. doi: 10.1016/j.surg.2024.02.015. Epub 2024 Apr 3.
5
Minimally invasive versus open pancreatoduodenectomy for pancreatic and peri-ampullary neoplasm (DIPLOMA-2): study protocol for an international multicenter patient-blinded randomized controlled trial.
Trials. 2023 Oct 12;24(1):665. doi: 10.1186/s13063-023-07657-7.
6
Robotic versus Open Pancreatoduodenectomy for Pancreatic and Periampullary Tumors (PORTAL): a study protocol for a multicenter phase III non-inferiority randomized controlled trial.
Trials. 2021 Dec 27;22(1):954. doi: 10.1186/s13063-021-05939-6.
7
[Early outcomes of open, laparoscopic and robot-assisted pancreatoduodenectomy].
Khirurgiia (Mosk). 2018(9):24-30. doi: 10.17116/hirurgia2018090124.
8
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial.
Lancet Gastroenterol Hepatol. 2019 Mar;4(3):199-207. doi: 10.1016/S2468-1253(19)30004-4. Epub 2019 Jan 24.
9
Perioperative and oncologic outcome of robot-assisted minimally invasive (hybrid laparoscopic and robotic) pancreatoduodenectomy: based on pancreatic fistula risk score and cancer/staging matched comparison with open pancreatoduodenectomy.
Surg Endosc. 2021 Apr;35(4):1675-1681. doi: 10.1007/s00464-020-07551-2. Epub 2020 Apr 10.
10
Learning curve of laparoscopic and robotic pancreas resections: a systematic review.
Surgery. 2021 Jul;170(1):194-206. doi: 10.1016/j.surg.2020.11.046. Epub 2021 Feb 2.
引用本文的文献
1
Laparoscopic management of intraductal oncocytic papillary neoplasm of the pancreas: Two case reports and review of literature.
World J Gastrointest Surg. 2025 Apr 27;17(4):105096. doi: 10.4240/wjgs.v17.i4.105096.
本文引用的文献
1
Cancer statistics, 2024.
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
2
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol. 2023 Nov;34(11):987-1002. doi: 10.1016/j.annonc.2023.08.009. Epub 2023 Sep 9.
3
Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trials.
Eur J Cancer. 2022 Jan;160:140-149. doi: 10.1016/j.ejca.2021.10.023. Epub 2021 Nov 24.
4
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.
PLoS Med. 2021 Mar 29;18(3):e1003583. doi: 10.1371/journal.pmed.1003583. eCollection 2021 Mar.
5
International consensus guidelines for surgery and the timing of intervention in chronic pancreatitis.
Pancreatology. 2020 Mar;20(2):149-157. doi: 10.1016/j.pan.2019.12.005. Epub 2019 Dec 17.
6
RoB 2: a revised tool for assessing risk of bias in randomised trials.
BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898.
7
Evaluation and Management of Neuroendocrine Tumors of the Pancreas.
Surg Clin North Am. 2019 Aug;99(4):793-814. doi: 10.1016/j.suc.2019.04.014. Epub 2019 May 27.
8
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial.
Lancet Gastroenterol Hepatol. 2019 Mar;4(3):199-207. doi: 10.1016/S2468-1253(19)30004-4. Epub 2019 Jan 24.
9
European evidence-based guidelines on pancreatic cystic neoplasms.
Gut. 2018 May;67(5):789-804. doi: 10.1136/gutjnl-2018-316027. Epub 2018 Mar 24.
10
Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial.
Lancet. 2017 Sep 9;390(10099):1027-1037. doi: 10.1016/S0140-6736(17)31960-8.
Zotero 插件